Nasdaq

Nexalin Technology, Inc. Launches Clinical Trial for HALO™ Clarity Device to Treat Mild Traumatic Brain Injury and PTSD at UCSD

Nexalin Technology announces the shipment of HALO™ Clarity devices to UCSD for a clinical trial on mTBI and PTSD treatment. Nexalin Technology, Inc. has announced that the University of California, ...
Nasdaq

Nexalin Technology, Inc. Receives IRB Approval for UCSD Clinical Trials of HALO™ Clarity Headset in Treating mTBI and PTSD

Nexalin Technology, Inc. has announced that it has received Institutional Review Board approval from the University of California, San Diego for clinical testing of its HALO™ Clarity headset, which ...